IDEXX Laboratories, Inc. (LON:0J8P)

Market Cap	31.32B
Revenue (ttm)	3.04B
Net Income (ttm)	692.69M
Shares Out	n/a
EPS (ttm)	8.37
PE Ratio	45.21
Forward PE	42.27
Dividend	n/a
Ex-Dividend Date	n/a

Volume	68
Average Volume	112
Open	519.76
Previous Close	520.81
Day's Range	519.76 - 526.03
52-Week Range	351.94 - 530.80
Beta	1.55
RSI	64.82
Earnings Date	Aug 4, 2025

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1983
• Employees: 11,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0J8P

Financial Performance

In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.

Financial numbers in USD